Developing medical technology for Diabetics to live a fearless life!
GlucoGear has the mission to improve glycemic control in patients with Diabetes, so they can live a fearless life! Pursuing this mission, GlucoGear developed an Artificial Intelligence to predict Blood Glucose curve hours ahead and identify risks of hypoglycemia and hyperglycemia. Consequently, we can optimize insulin dosage and recommend preventive actions to avoid adverse effects. This new preventive approach enables to improve clinical outcome and quality of life of T1D patients while decreasing hospitalization and treatment costs. This intelligence may be integrated into a Mobile App like our own, GlucoTrends app, embedded on medical devices like Continuous Glucose Monitors (CGM) and Insulin Pumps, or being the intelligence behind an Artificial Pancreas, adding predictive and personalized recommendations to those devices.
Total Funding: $250,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 1 to 25
Founded: 2015
